From Our Web Site
PPD's pharmaceutical R&D unit will have the chance to grow independent of the contract research business, which will now have a bigger foothold in the huge Chinese market, and the parent company increases its access to a new-product pipeline.
Rifaximin, Apriso and Moviprep were topics of poster and oral presentations.
The developer of metabolomics for use as research and diagnostic tools closed the first portion of the funding round at more than $5 million on April 30.
The privately held 9-year-old firm has drug-exploration contracts with numerous major pharmaceutical companies.
Initial study by researchers at N.C. State, NIEHS and The Hamner Institutes shows reversible changes in outer lining of mouse lungs, but it's still unknown if long-term exposure would cause asbestos-like health problems.
The Duke spin-out, started with the help of a $10,000 North Carolina Biotechnology Center loan, said its study results are "unprecedented for an immunotherapeutic candidate in HIV" that "could lead to a new treatment paradigm for HIV."
Centice has now raised more than $21 million since it was founded in 2004.
Greensboro's growing bioscience industry and it's valuable training programs has helped bring Ameritox, and 228 jobs, to the Triad.
|
Are you going to 
A panel of bioscience industry executives will meet at the Biotechnology Center Friday to participate in the Fifth Annual BioSciences Forum. The BioSciences Management Initiative at North Carolina State University's College of Management is presenting the free event, with speakers from Athenix, Corp., the David H. Murdoch Research Institute, Synecor and others.